Farms.com Home   News

New Cattle Market Bill Aims to Increase Transparency

Recently introduced legislation would create greater price discovery and transparency within the cattle market, while giving producers more tools and useful information. The Farm Bureau-backed Optimizing the Cattle Market Act of 2021 would direct USDA to create a cattle formula contracts library and increase the reporting window for “cattle committed” from seven to 14 days.

The bill would also require USDA, in consultation with the department’s chief economist, to establish mandated minimums for regional negotiated cash and negotiated grid live cattle trade.

“America’s families are paying more for meat at the grocery store while rock bottom prices are paid to farmers. Ranchers can’t continue to lose money on the cattle they work hard to raise. Farmers and ranchers have legitimate questions, and this legislation takes important steps toward ensuring they have fair access to markets and are fully informed on pricing,” said American Farm Bureau Federation President Zippy Duvall. “We appreciate Representative Hartzler (R-Mo.) and Representative Cleaver (D-Mo.) for introducing the Optimizing the Cattle Market Act of 2021 and we look forward to working with Congress to make certain farmers and ranchers can continue to put dinner on the table in homes across America.”

 

Click here to see more...

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.